生物製藥輔料市場規模、佔有率和成長分析（按產品、功能、應用、最終用戶和地區分類）—2026-2033年產業預測

全球生物製藥輔料市場規模預計在 2024 年達到 24.3 億美元，從 2025 年的 25.7 億美元成長到 2033 年的 39.7 億美元，在預測期（2026-2033 年）內複合年成長率為 5.6%。

受生物製藥需求成長、個人化醫療理念日益受到重視以及生物技術領域顯著進步的推動，全球生物製藥輔料市場正經歷強勁成長。癌症和自體免疫疾病等慢性病的流行促使人們更加需要標靶治療，也使得特殊輔料在提高藥物療效和減少副作用方面的作用更加凸顯。此外，從傳統小分子藥物轉變為生物製藥的轉變進一步推動了對這些輔料的需求。然而，該市場仍面臨諸多挑戰，包括複雜的法規環境導致核准流程繁瑣並增加了營運成本。此外，生物製藥輔料的高成本，且依賴先進技術和專業生產設施，也限制了其廣泛應用。

推動全球生物製藥輔料市場發展的因素

慢性病發病率的上升和人口老化的加劇顯著增加了對生物製藥產品的需求。由於生物製藥能夠提供個人化和高效的治療方案，對專用輔料的需求也隨之增強。這些輔料在提高複雜藥物產品的穩定性、溶解度和遞送效率方面發揮關鍵作用，推動了生物製藥輔料市場的擴張。隨著醫療機構越來越重視有效的治療方法，創新型輔料的重要性日益凸顯，進一步促進了生物製藥產業這個充滿活力的細分領域的整體成長和發展。

全球生物製藥輔料市場面臨的限制因素

全球生物製藥輔料市場面臨許多限制因素，其中生物製藥核准流程的嚴格性和複雜性尤其突出。生物製藥輔料的廣泛測試和檢驗要求對生產者構成了一大障礙。遵守各項監管標準極具挑戰性，最終可能阻礙市場成長。隨著市場對高品質輔料的需求不斷成長，生產商必須在確保嚴格合規的同時進行創新，這是他們必須應對的雙重挑戰，才能充分掌握市場機會。

生物製藥輔料市場的全球趨勢

全球生物製藥輔料市場正呈現一個顯著趨勢：對旨在滿足生物製藥製劑特定需求的特種功能輔料的需求日益成長。隨著生物製藥領域的拓展和發展，人們對具有先進功能的輔料越來越感興趣，例如蛋白質穩定、藥物控釋機制和增強溶解度。這些特殊輔料有助於開發更有效、更有效率的藥物遞送系統，推動創新並協助複雜生物製藥製劑的配製。這一趨勢反映了生物製藥行業向個人化和客製化治療的廣泛轉變。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球生物製藥輔料市場規模（依產品分類）及複合年成長率（2026-2033 年）

• 碳水化合物
  • 葡萄糖
  • 澱粉
  • 蔗糖
• 多元醇類
  • 甘露醇
  • 山梨醇
• 增溶劑、界面活性劑、乳化劑
  • 酯類
  • 三酸甘油酯
• 特殊輔料

全球生物製藥輔料市場規模（依功能分類）及複合年成長率（2026-2033 年）

• 粘合劑
• 塗層劑
• 崩壞
• 潤滑劑和拖鞋
• 醫藥填充劑
• 防腐劑

全球生物製藥輔料市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 先進交付系統
• 口服
• 腸外
• 外用藥物

全球生物製藥輔料市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 契約製造公司
• 製藥和生物技術公司

全球生物製藥輔料市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Merck KGaA（Germany）
• BASF SE（Germany）
• Evonik Industries AG（Germany）
• Roquette Freres（France）
• Colorcon, Inc.（USA）
• DFE Pharma（Germany）
• Avantor, Inc.（USA）
• Kerry Group plc（Ireland）
• Associated British Foods plc（UK）
• Wacker Chemie AG（Germany）
• Lubrizol Corporation（USA）
• J. Rettenmaier & Sohne GmbH+Co KG（Germany）
• SPI Pharma（USA）
• Fuji Chemical Industries Co., Ltd.（Japan）
• Meggle GmbH & Co. KG（Germany）
• Beneo GmbH（Germany）

結論與建議

Global Biopharmaceuticals Excipients Market size was valued at USD 2.43 Billion in 2024 and is poised to grow from USD 2.57 Billion in 2025 to USD 3.97 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global biopharmaceuticals excipients market is witnessing robust growth, driven by the rising demand for biopharmaceutical drugs, increased emphasis on personalized medicine, and notable advancements in biotechnology. The prevalence of chronic conditions, such as cancer and autoimmune diseases, has intensified the need for targeted treatments, elevating the role of specialized excipients in enhancing drug efficacy and reducing side effects. Moreover, the transition towards biologics over traditional small molecules further fuels demand for these excipients. However, the market faces challenges, including a complex regulatory environment that complicates the approval processes and escalates operational costs. Additionally, the high costs associated with manufacturing biopharmaceutical excipients limit broader adoption, given their reliance on advanced technologies and specialized production facilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceuticals Excipients Market Segments Analysis

Global Biopharmaceuticals Excipients Market is segmented by Product, Function, Application, End User and region. Based on Product, the market is segmented into Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers and Specialty Excipients. Based on Function, the market is segmented into Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers and Preservatives. Based on Application, the market is segmented into Advanced Delivery System, Oral, Parenteral and Topical. Based on End User, the market is segmented into Contract Manufacturing Organizations and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceuticals Excipients Market

The growing incidence of chronic illnesses, alongside an expanding elderly demographic, has significantly boosted the demand for biopharmaceutical products. Biologics provide tailored and more efficient treatment options, which in turn heightens the necessity for specialized excipients. These excipients play a crucial role in improving the stability, solubility, and delivery of these complex medications, thereby fueling the expansion of the biopharmaceutical excipients market. As healthcare providers increasingly prioritize effective treatment modalities, the importance of innovative excipients continues to rise, contributing to the overall growth and evolution of this dynamic sector within the biopharmaceutical industry.

Restraints in the Global Biopharmaceuticals Excipients Market

The Global Biopharmaceuticals Excipients market faces significant constraints due to the stringent and intricate approval processes for biopharmaceutical drugs. The thorough testing and validation requirements for excipients utilized in biologic formulations create obstacles for manufacturers. Navigating through a range of regulatory standards can be quite challenging, which may ultimately impede the growth of the market. As the demand for high-quality excipients increases, manufacturers must ensure rigorous compliance while also innovating, thereby presenting a dual challenge that needs to be addressed to fully capitalize on opportunities within the market landscape.

Market Trends of the Global Biopharmaceuticals Excipients Market

The Global Biopharmaceuticals Excipients market is witnessing a significant trend towards the increased demand for specialty and functional excipients designed to meet the specific needs of biopharmaceutical formulations. As the biologics sector expands and evolves, there is a marked interest in excipients that offer enhanced functionalities, including protein stabilization, controlled drug release mechanisms, and improved solubility. These specialized excipients facilitate the development of more effective and efficient drug delivery systems, driving innovation and supporting the formulation of complex biologic products. This trend reflects the broader shift towards personalized and tailored therapeutics in the biopharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biopharmaceuticals Excipients Market Size by Product & CAGR (2026-2033)

• Market Overview
• Carbohydrates
  • Dextrose
  • Starch
  • Sucrose
• Polyols
  • Mannitol
  • Sorbitol
• Solubilizers & Surfactants/Emulsifiers
  • Esters
  • Triglycerides
• Specialty Excipients

Global Biopharmaceuticals Excipients Market Size by Function & CAGR (2026-2033)

• Market Overview
• Binders
• Coatings
• Disintegrants
• Lubricants & glidants
• Pharmaceutical Fillers
• Preservatives

Global Biopharmaceuticals Excipients Market Size by Application & CAGR (2026-2033)

• Market Overview
• Advanced Delivery System
• Oral
• Parenteral
• Topical

Global Biopharmaceuticals Excipients Market Size by End User & CAGR (2026-2033)

• Market Overview
• Contract Manufacturing Organizations
• Pharmaceutical & Biotechnology Companies

Global Biopharmaceuticals Excipients Market Size & CAGR (2026-2033)

• North America (Product, Function, Application, End User)
  • US
  • Canada
• Europe (Product, Function, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Function, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Function, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Function, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lubrizol Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J. Rettenmaier & Sohne GmbH + Co KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPI Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industries Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meggle GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beneo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations